Download PDFPDF

Prevalence of spondyloarthropathies in France: 2001
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

  • Published on:
    Recalculation of the prevalence rates of ankylosing spondylitis and

    Dear Editor,

    We thank Dr Akkoc for his interest in our article (1) and welcome his comments. He have taken the challenge to recalculate our data using age and sex distributions of the patients with different categories and the age and sex distributions of the sample reported in our two companion papers (1, 2). As detailed in the methodology chapter, we took into account both the proportion of the county population...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Recalculation of the prevalence rates of ankylosing spondylitis and psoriatic arthritis in France
    • Nurullah Akkoc, Professor of Medicine
    • Other Contributors:
      • Fatos Onen, Yesim Akkoc

    Dear Editor,

    We read the study by Saraux et al (1) on the prevalence of Spondyloathropaties (SpA)s in France with great interest. In this well designed study, 9395 subjects were interviewed over the phone using a structured questionnaire. SpA was confirmed in 29 patients by the patient’s rheumatologist or by clinical examination. Of these 29 patients, 13 had ankylosing spondylitis (AS) and 11 had psoriatic arthri...

    Show More
    Conflict of Interest:
    None declared.